Showing results (141-150 of 193) with videos related to

Sort By:
Pageof 20
Oncotarget|October 6, 2015
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signatureMarina Díaz-Beyá, Salut Brunet, Josep Nomdedéu, et al.
Cancer|January 31, 2013
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab)Josep-Maria Ribera, Olga García, Carlos Grande, et al.
Bone Marrow Transplantation|February 27, 2019
Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working PartyKai Hübel, Alessandro Re, Ariane Boumendil, et al.
American Journal of Clinical Pathology|August 16, 2015
Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AMLMaria Concepcion García-Dabrio, Montserrat Hoyos, Salut Brunet, et al.
Hematological Oncology|May 4, 2016
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approachJosep F Nomdedéu, Eulalia Puigdecanet, Elena Bussaglia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 11, 2010
Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft sourceChristelle Ferrá, Jaime Sanz, Rafael de la Cámara, et al.
Bone Marrow Transplantation|June 1, 2022
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalanFrancesca Guijarro, Alex Bataller, Marina Diaz-Beyá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2025
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospectsPilar Mur, Anna Pozuelo, Josep Tabernero, et al.
Leukemia & Lymphoma|June 11, 2014
Outcome of graft failure after allogeneic stem cell transplant: study of 89 patientsChristelle Ferrà, Jaime Sanz, Miguel-Angel Díaz-Pérez, et al.
Bone Marrow Transplantation|February 22, 2018
Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow TransplantationIrit Avivi, Ariane Boumendil, Hervé Finel, et al.
Pageof 20